And NVDAIt's time MTTR earnings, not feeling good.
- 1
And NVDAIt's time MTTR earnings, not feeling good.
Hate how much it ran up into earnings.And NVDA
So you mentioned subscribers being the key metric for long-term viability for the company... +98% is good news, yeah?
see my edit. Good sub numbers but they are giving it away.So you mentioned subscribers being the key metric for long-term viability for the company... +98% is good news, yeah?
Like many big pharma they just have too much revenue concentration. Right now market is having faith in them, but it can turn on these companies very quickly. They are essentially the same company that traded down into the $60s. I think it's a great company but this is likely peak Revenue for them for the foreseeable future unless we get some surprises in the pipeline. How the company will trade during those coming declining revenues as Humira runs off is tough to predict. It's has been an easy hold for awhile, ownership through '24 may not be all roses and sunshine. Gilead is always a great example, managing these companies is extremely difficult. How much to spend on R&D how much to pay back to shareholders how much to spend on acquisitions is a constant balancing act.
Me holding MTTR right now:see my edit. Good sub numbers but they are giving it away.
View attachment 398759
They need big numbers on the enterprise side, the revenue numbers show that it's too much on the pittance side. By my math they averaged $32 per sub for the QTR that is not good enough.
Imagine the clustering of complete weirdos in that neighborhood.
Pretty sure we talked about this back in early December. I helped my mom and dad put $40k in by doing for '21 and '22 . You can buy them right from treasurydirect.govWas listening to the radio today and they were talking about investing in something right now that has almost no risk..
The "I" bond:
intesrst rate 7.12% for an I bond through end of april - you just have to hold it for a year. The interest rate is tied to CPI
Apparently the amount you can buy is capped at 10,000 per person.
Looks to be essentially a guaranteed 7.12 % on your investment and you can hold it for more than a year but you have to hold it for a minimum of a year.
![]()
Investors Flock to ‘I Savings Bonds’ for Protection Against Inflation
They have all sorts of advantages for those worried about rising prices. One caveat: There is no secondary market.www.wsj.com
Something for everyone to keep in mind also is that MTTR is a microcap. Roughly estimating about $100m in annual revenue. In the scope of things that is really, really tiny. And they are losing 10-15 cents a share (projected) to generate that subscriber growth to grow revenue. For perspective, one of my partner's companies (the one I dont own any of, of course) does $90m with a 10-15% growth rate and runs over a 20% profit margin. It has been around for 30 years and it took over 20 years to really begin to scale up to its level of revenue and profit. It had a fuckton of quite lean years. So with MTTR its all about investing for returns long into the future. There is nothing wrong with that but investors also consider opportunity costs of letting their money sit while waiting.It sucks to shit on a company that is growing subs at 100% YoY but important to remember we aren't shitting on the company it's shitty on the stock price. My first pass at the math, I'd say the company is currently worth about $5.00-$5.75/share at this performance level.
10k is pretty standard issue price for a bond.Was listening to the radio today and they were talking about investing in something right now that has almost no risk..
The "I" bond:
intesrst rate 7.12% for an I bond through end of april - you just have to hold it for a year. The interest rate is tied to CPI
Apparently the amount you can buy is capped at 10,000 per person.
Looks to be essentially a guaranteed 7.12 % on your investment and you can hold it for more than a year but you have to hold it for a minimum of a year.
![]()
Investors Flock to ‘I Savings Bonds’ for Protection Against Inflation
They have all sorts of advantages for those worried about rising prices. One caveat: There is no secondary market.www.wsj.com